The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mutational activation of c-raf-1 and definition of the minimal transforming sequence.
Open accessAbstract
A series of wild-type and mutant raf genes was transfected into NIH 3T3 cells and analyzed for transforming activity. Full-length wild-type c-raf did not show transforming activity. Two types of mutations resulted in oncogenic activity similar to that of v-raf: truncation of the amino-terminal half of the protein and fusion of the full-length molecule to gag sequences. A lower level of activation was observed for a mutant with a tetrapeptide insertion mapping to conserved region 2 (CR2), a serine- and threonine-rich domain located 100 residues amino-terminal of the kinase domain. To determine essential structural features of the transforming region of raf, we analyzed point and deletion mutants of v-raf. Substitutions of Lys-56 modulated the transforming activity, whereas mutation of Lys-53, a putative ATP binding residue, abolished it. Deletion analysis established that the minimal transforming sequence coincided precisely with CR3, the conserved Raf kinase domain. Thus, oncogenic activation of the Raf kinase can be achieved by removal of CR1 and CR2 or by steric distortion and requires retention of an active kinase domain. These findings are consistent with a protein structure model for the nonstimulated enzyme in which the active site is buried within the protein.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
Cited by
Mammalian Ras interacts directly with the serine/threonine kinase raf
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,941
Kieber, J. J., Rothenberg, M., Roman, G., Feldmann, K. A., & Ecker, J. R. (1993) · Cell · doi:10.1016/0092-8674(93)90119-b · Cited by 1,923
Protein kinase Cα activates RAF-1 by direct phosphorylation
Kolch, W., Heidecker, G., Kochs, G., Hummel, R., Vahidi, H., Mischak, H., Finkenzeller, G., Marmé, D., & Rapp, U. R. (1993) · Nature · doi:10.1038/364249a0 · Cited by 1,277
Self-citationDifferential Activation of ERK and JNK Mitogen-Activated Protein Kinases by Raf-1 and MEKK
Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Dérijard, B., Davis, R. J., Johnson, G. L., & Karin, M. (1994) · Science · doi:10.1126/science.7992057 · Cited by 1,069
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies
Bahar, M. E., Kim, H. J., & Kim, D. R. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01705-z · Cited by 888
Cobb, M. H. (1999) · Progress in Biophysics and Molecular Biology · doi:10.1016/s0079-6107(98)00056-x · Cited by 875
Tumor Regression by Targeted Gene Delivery to the Neovasculature
Hood, J. D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R. A., Xiang, R., & Cheresh, D. A. (2002) · Science · doi:10.1126/science.1070200 · Cited by 858
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
Zhang, X.-F., Settleman, J., Kyriakis, J., Takeuchi-Suzuki, E., Elledge, S. J., Marshall, M. S., Bruder, J. T., Rapp, U. R., & Avruch, J. (1993) · Nature · doi:10.1038/364308a0 · Cited by 858
Self-citationTargeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Holderfield, M., Deuker, M. M., McCormick, F., & McMahon, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3760 · Cited by 833
Blocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831
Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by Akt
Rommel, C., Clarke, B. A., Zimmermann, S., Nuñez, L., Rossman, R., Reid, K., Moelling, K., Yancopoulos, G. D., & Glass, D. J. (1999) · Science · doi:10.1126/science.286.5445.1738 · Cited by 758
Regulation of RAF protein kinases in ERK signalling
Lavoie, H., & Therrien, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3979 · Cited by 702
Activation of Mitogen-Activated Protein Kinase Kinase by v-Raf in NIH 3T3 Cells and in Vitro
Dent, P., Haser, W., Haystead, T. A. J., Vincent, L. A., Roberts, T. M., & Sturgill, T. W. (1992) · Science · doi:10.1126/science.1326789 · Cited by 668
The complexity of Raf-1 regulation
Morrison, D. K., & Cutler, R. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80060-9 · Cited by 635
Regulation of Raf-1 by Direct Feedback Phosphorylation
Dougherty, M. K., Müller, J., Ritt, D. A., Zhou, M., Zhou, X. Z., Copeland, T. D., Conrads, T. P., Veenstra, T. D., Lu, K. P., & Morrison, D. K. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.055 · Cited by 633
Complex formation between RAS and RAF and other protein kinases.
Van Aelst, L., Barr, M., Marcus, S., Polverino, A., & Wigler, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6213 · Cited by 622
Germline gain-of-function mutations in SOS1 cause Noonan syndrome
Roberts, A. E., Araki, T., Swanson, K. D., Montgomery, K. T., Schiripo, T. A., Joshi, V. A., Li, L., Yassin, Y., Tamburino, A. M., Neel, B. G., et al. (2007) · Nature Genetics · doi:10.1038/ng1926 · Cited by 605
Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
Rowinsky, E. K., Windle, J. J., & Von Hoff, D. D. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3631 · Cited by 537
The ins and outs of Raf kinases
Daum, G., Eisenmann-Tappe, I., Fries, H.-W., Troppmair, J., & Rapp, U. R. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90133-3 · Cited by 524
Self-citationThe Role of Ethylene in Host-Pathogen Interactions
Broekaert, W. F., Delauré, S. L., De Bolle, M. F. C., & Cammue, B. P. A. (2006) · Annual Review of Phytopathology · doi:10.1146/annurev.phyto.44.070505.143440 · Cited by 503
Germline gain-of-function mutations in RAF1 cause Noonan syndrome
Razzaque, M. A., Nishizawa, T., Komoike, Y., Yagi, H., Furutani, M., Amo, R., Kamisago, M., Momma, K., Katayama, H., Nakagawa, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2078 · Cited by 498
CHEN, Y.-F., ETHERIDGE, N., & SCHALLER, G. E. (2005) · Annals of Botany · doi:10.1093/aob/mci100 · Cited by 495
Raf-1 protein kinase is required for growth of induced NIH/3T3 cells
Kolch, W., Heidecker, G., Lloyd, P., & Rapp, U. R. (1991) · Nature · doi:10.1038/349426a0 · Cited by 474
Self-citationMonia, B. P., Johnston, J. F., Geiger, T., Muller, M., & Fabbro, D. (1996) · Nature Medicine · doi:10.1038/nm0696-668 · Cited by 447
Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.
Bruder, J. T., Heidecker, G., & Rapp, U. R. (1992) · Genes & Development · doi:10.1101/gad.6.4.545 · Cited by 444
Self-citationCancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
Collier, L. S., Carlson, C. M., Ravimohan, S., Dupuy, A. J., & Largaespada, D. A. (2005) · Nature · doi:10.1038/nature03681 · Cited by 406
Mechanisms of regulating the Raf kinase family
Chong, H., Vikis, H. G., & Guan, K.-L. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00139-0 · Cited by 405
Huang, Y., Li, H., Hutchison, C. E., Laskey, J., & Kieber, J. J. (2003) · The Plant Journal · doi:10.1046/j.1365-313x.2003.01620.x · Cited by 404
Raf Family Kinases: Old Dogs Have Learned New Tricks
Matallanas, D., Birtwistle, M., Romano, D., Zebisch, A., Rauch, J., von Kriegsheim, A., & Kolch, W. (2011) · Genes & Cancer · doi:10.1177/1947601911407323 · Cited by 386
Self-citationCritical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.
Fabian, J. R., Daar, I. O., & Morrison, D. K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7170 · Cited by 353
Teramoto, H., Coso, O. A., Miyata, H., Igishi, T., Miki, T., & Gutkind, J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27225 · Cited by 343
Smeal, T., Binetruy, B., Mercola, D., Grover-Bardwick, A., Heidecker, G., Rapp, U. R., & Karin, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.8.3507 · Cited by 335
Self-citationRaf kinases: Function, regulation and role in human cancer
Leicht, D. T., Balan, V., Kaplun, A., Singh-Gupta, V., Kaplun, L., Dobson, M., & Tzivion, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.05.001 · Cited by 317
Mechanism of inhibition of Raf-1 by protein kinase A
Häfner, S., Adler, H. S., Mischak, H., Janosch, P., Heidecker, G., Wolfman, A., Pippig, S., Lohse, M., Ueffing, M., & Kolch, W. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6696 · Cited by 312
Self-citationRaf functions downstream of Rasl in the Sevenless signal transduction pathway
Dickson, B., Sprenger, F., Morrison, D., & Hafen, E. (1992) · Nature · doi:10.1038/360600a0 · Cited by 312
Raf: A Strategic Target for Therapeutic Development Against Cancer
Beeram, M., Patnaik, A., & Rowinsky, E. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.036 · Cited by 298
Stimulatory Effects of Yeast and Mammalian 14-3-3 Proteins on the Raf Protein Kinase
Irie, K., Gotoh, Y., Yashar, B. M., Errede, B., Nishida, E., & Matsumoto, K. (1994) · Science · doi:10.1126/science.8085159 · Cited by 294
Frost, J. A., Xu, S., Hutchison, M. R., Marcus, S., & Cobb, M. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3707 · Cited by 274
p50cdc37 Acting in Concert with Hsp90 Is Required for Raf-1 Function
Grammatikakis, N., Lin, J.-H., Grammatikakis, A., Tsichlis, P. N., & Cochran, B. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1661 · Cited by 261
Frequent Gains at Chromosome 7q34 Involving BRAF in Pilocytic Astrocytoma
Bar, E. E., Lin, A., Tihan, T., Burger, P. C., & Eberhart, C. G. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181845622 · Cited by 261
Cross-talk between JNK/SAPK and ERK/MAPK Pathways
Shen, Y. H., Godlewski, J., Zhu, J., Sathyanarayana, P., Leaner, V., Birrer, M. J., Rana, A., & Tzivion, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303264200 · Cited by 190
Wu, J., Ivanov, A. I., Fisher, P. B., & Fu, Z. (2016) · eLife · doi:10.7554/elife.10734 · Cited by 117
Flory, E., Weber, C. K., Chen, P., Hoffmeyer, A., Jassoy, C., & Rapp, U. R. (1998) · Journal of Virology · doi:10.1128/jvi.72.4.2788-2794.1998 · Cited by 55
Self-citationMicrotubule Integrity Regulates Pak Leading to Ras-independent Activation of Raf-1
Zang, M., Waelde, C. A., Xiang, X., Rana, A., Wen, R., & Luo, Z. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100152200 · Cited by 48
Dynamic Protein Allosteric Regulation and Disease
Nussinov, R., Tsai, C.-J., & Jang, H. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-8719-7_2 · Cited by 18
Metadata
- Authors
- Heidecker, G., Huleihel, M., Cleveland, J. L., Kolch, W., Beck, T. W., Lloyd, P., Pawson, T., & Rapp, U. R.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1990-06
- Volume
- 10
- Issue
- 6
- Pages
- 2503-2512
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2143678301
- Cited by
- 240
- References
- 1
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.